Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland – the SAKK 95/16 prostate study. Swiss Medical Weekly, [S. l.], v. 151, n. 0910, p. w20464, 2021. DOI: 10.4414/smw.2021.20464. Disponível em: https://smw.ch/index.php/smw/article/view/2968. Acesso em: 14 oct. 2025.